The Heads of Medicines Agencies (HMA) is a network of the Heads of the National Competent Authorities whose organiza-tions are responsible for the regulation of Medicinal Products for human and veterinary use in the European Economic Area. They focus on EU coordination and harmonisation, decision-making and con-sensus on strategic
issues on the European Medicines Regulatory Network, with an aim at promoting and protecting human and animal health by ensuring that patients and animals have access to medicinal products which are of a high standard of quality, safety and efficacy. Within this network pharmaco-vigilance, risk management, enforcement and quality issues became part of the core business activities.
The heads of the Competent Authorities of the Member States provide a guiding framework within the Community system of legislation and regulation processes of medicines, as well as a common forum for the exchange of views on issues of interest to the Community.
The HMA cooperates with the European Medicines Agency and the European Commission in the operation of the European Medicines Regulatory Network. The Heads of Medicines Agencies is supported by working groups covering specific areas of responsibility and by the HMA Management Group and Permanent Secretariat.